​

Pyxis Oncology (PYXS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Pyxis Oncology Revenue Highlights

Latest Revenue (Y)

$13.86M

0

Main Segment (Y)

Milestone Revenue

Pyxis Oncology Revenue by Period

Pyxis Oncology Revenue by Year

DateRevenueChange
2025-12-31$13.86M-14.17%
2024-12-31$16.15M100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Pyxis Oncology generated $13.86M in revenue during NA 2025, up -14.17% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Pyxis Oncology Revenue by Quarter

DateRevenueChange
2025-09-30--100.00%
2025-06-30$2.82M100.00%
2025-03-31--100.00%
2024-12-31$3.40M100.00%
2024-09-30-100.00%
2024-06-30--100.00%
2024-03-31$16.15M372.11%
2023-12-31$3.42M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Pyxis Oncology generated - in revenue during Q3 2025, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Pyxis Oncology Revenue Breakdown

Pyxis Oncology Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25
Milestone Revenue$2.82M

Pyxis Oncology's latest annual revenue breakdown by segment (product or service), as of Dec 25: Milestone Revenue (100.00%).

Quarterly Revenue by Product

Product/ServiceDec 25Sep 25Sep 24Jun 24Mar 24
Milestone Revenue-$2.82M---
Royalty--$8.15M$8.15M$8.15M

Pyxis Oncology Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ENTAEnanta Pharmaceuticals$65.32M$18.61M
VYGRVoyager Therapeutics$40.37M$13.37M
FHTXFoghorn Therapeutics$30.91M$8.15M
PYXSPyxis Oncology$13.86M-
HUMAHumacyte$2.04M$753.00K
IMRXImmuneering--
ZURAZura Bio--
CRBUCaribou Biosciences--
TNYATenaya Therapeutics--
AVIRAtea Pharmaceuticals--

PYXS Revenue FAQ

What is Pyxis Oncology’s yearly revenue?

Pyxis Oncology's yearly revenue for 2025 was $13.86M, representing a decrease of -14.17% compared to 2024. The company's yearly revenue for 2024 was $16.15M, representing an increase of 100.00% compared to 2023. PYXS's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022.

What is Pyxis Oncology’s quarterly revenue?

Pyxis Oncology's quarterly revenue for Q3 2025 was $0, a -100.00% decrease from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $2.82M, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). PYXS's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a -100.00% decrease year-over-year (Q1 2024).

What is Pyxis Oncology’s revenue growth rate?

Pyxis Oncology's revenue growth rate for the last 3 years (2023-2025) was 0%, and for the last 5 years (2021-2025) was 0%.

What are Pyxis Oncology’s revenue streams?

Pyxis Oncology's revenue streams in c 25 are Milestone Revenue

What is Pyxis Oncology’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Pyxis Oncology was Milestone Revenue. This segment made a revenue of $2.82M, representing 100.00% of the company's total revenue.